Abstract
Background
Craniopharyngioma is a frequent tumor in children with challenging surgical, endocrine, and visual consequences. We evaluated our experience in treating craniopharyngioma and its incidence in Macedonia.
Methods
Thirteen children (9 male and 4 female) with craniopharyngioma (age 9.55±3.74 years; range 2.90–15.11) who had been treated between 1989 and 2008 in Macedonia were reviewed.
Results
Initial signs were vision disturbances (10 children), seizures (1), growth retardation (13), and diabetes insipidus (DI) (2). All children were subjected to subtotal surgical removal. Cranial irradiation was performed in 12 of the 13 children, and intracystic bleomycin was given to one child. The patients were followed up for 6–229 months (mean ± SD: 107.00±74.04 months). All children had multiple pituitary deficiencies after surgical removal of the tumor. Body mass index increased from 16.93±6.34 standard deviation scores (SDS) at diagnosis to 26.33±5.91 SDS (P>0.005) at the last follow-up. DI was permanent in 9 of the 13 children, and multiple pituitary deficiencies were seen in all children. Treatment with growth hormone resulted in normalization of adult height from -1.27±1.52 SDS at the start of the treatment to −0.13±1.39 SDS at the last followup. The final height was not significantly lower than the genetic target height (P>0.005). The permanent deficit was visual impairment: blindness in one or both eyes in 4 children, bitemporal hemianopsia in 4, and other defects in 2. Recurrence of the disease was ruled out in one child after 31 months. No mortality was observed in the observation period of 104.92±76.11 months.
Conclusions
The overall incidence of craniopharyngioma in the period of 1989–2008 in Macedonia was 1.43 per 1 000 000 person-years. Subtotal resection and systematic irradiation showed good life quality of survivors.
Similar content being viewed by others
References
Karavitaki N, Cudlip S, Adams CB, Wass JA. Craniopharyngiomas. Endocr Rev 2006;27:371–397.
Hogeveen M, Noordam C, Otten B, Wit JM, Massa G. Growth before and during growth hormone treatment in children operated for craniopharyngioma. Horm Res 1997;48:258–262.
Lyen KR, Grant DB. Endocrine function, morbidity and mortality after surgery for craniopharyngioma. Arch Dis Child 1982;57:837–841.
Karavitaki N, Brufani C, Warner JT, Adams CB, Richards P, Ansorge O, et al. Cranyopharyngeomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 2005;62:397–409.
Sorva R. Children with cranyopharynhioma: early growth failure and rapid post-operative weight gain. Acta Paediatr Scand 1988;77:587–592.
Thomsett MJ, Conte FA, Kaplan SL, Grumbach MM. Endocine and neurologic outcome in childhood craniopharyngioma: review of effect of treatment in 42 patients. J Pediatr 1980;97:728–735.
Boch AL, Van Effenterre R, Kujas M. Craniophrayngiomas in two consanguineous siblings: case report. Neurosurgery 1997;41:1185–1187.
Fahlbusch R, Honegger J, Paulus W, Huk W, Buchfelder M. Surgical treatment of craniophariniomas: experience with 168 patients. J Neurosurg 1999;90:237–250.
Pereira AM, Schmid EM, Schutte PJ, Voormolen JH, Biermasz NR, van Thiel SW, et al. High prevalence of long-term cardiovascular, neurological and psychosocial morbidity after treatment for craniopharyngioma. Clin Endocrinol (Oxf) 2005;62:197–204.
Stripp DC, Maity A, Janss AJ, Belasco JB, Tochner ZA, Goldwein JW, et al. Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults. Int J Radiat Oncol Biol Phys 2004;58:714–720.
Brook CD. Growth assessment in childhood and adolescence. Oxford: Blackwell Scientific Publications, 1982.
WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards Based on length, height, weight and age. Acta Paediatr Suppl 2006;450:76–85.
Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i–xii, 1–253.
Puget S, Garnett M, Wray A, Grill J, Habrand JL, Bodaert N, et al. Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg 2007;106:3–12.
Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J Neurosurg 1988;89:547–551.
Haupt R, Magnani C, Pavanello M, Caruso S, Dama E, Garrè ML. Epidemiological aspects of craniopharyngioma. J Pediatr Endocrinol Metab 2006;19Suppl 1:289–293.
Mori K, Kurisaka M. Brain tumors in childhood: statistical analysis of cases from the Brain Tumor Registry of Japan. Child Nerv Syst 1986;2:233–237.
Erşahin Y, Yurtseven T, Ozgiray E, Mutluer S. Craniopharyngiomas in children: Turkey experience. Childs Nerv Syst 2005;21:766–772.
Muller HL. Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up. Horm Res 2008;69:193–202.
Ohmori K, Collins J, Fukushima T. Craniopharyngiomas in children. Pediatr Neurosurg 2007;43:265–278.
Banna M, Hoare RD, Stanley P, Till K. Cranyopharyngeoma in children. J Pediatr 1973;83:781–785.
Ono N, Kohga H, Zama A, Inoue HK, Tamura M. A comparison of children with suprasellar germ cell tumors and cariopharyngiomas: final height, weight, endocrine and visual sequelae after treatment. Surg Neurol 1996;46:370–377.
de Vries L, Lazar L, Phillip M. Craniopharyngioma: presentation and endocrine sequelae in 36 children. J Pediatr Endocrinol Metab 2003;16:703–710.
Tiulpakov AN, Mazerkina NA, Brook CG, Hindmarsh PC, Peterkova VA, Gorelyshev SK. Growth in children with craniopharyngioma following surgery. Clin Endocrinol (Oxf) 1998;49:733–738.
DeVile C, Grant DB, Hayward RD, Stanhope R. Growth and endocrine sequelae of cranyopharyngioma. Arch Dis Child 1966;75:108–114.
Paja M, Lucas T, Garcia-Uria J, Salame F, Barcelo B, Estrada J. Hypothalamic-Pituitary dysfunction in patients with craniopharyngioma. Clin Endocrinol (Oxf) 1995;42:467–473.
Merchant TE, Kiehna EN, Sanford RA, Mulhern RK, Thompson SJ, Wilson MW, et al. Craniopharyngioma: the St. Jude Children’s Research Hospital experience 1984–2001. Int J Radiat Oncol Biol Phys 2002;53:533–542.
Fischer EG, Welch K, Shillito J Jr, Winston KR, Tarbell NJ. Craniopharyngiomas in children. Long-term effects of conservative surgical procedures combined with radiation therapy. J Neurosurg 1990;73:534–540.
Hukin J, Visser J, Sargent M, Goddard K, Fryer C, Steinbok P. Childhood craniopharingioma: Vancouver experience. Childs Nerv Syst 2005;21:758–765.
Thompson D, Phipps K, Hayward R. Cranyopharyngioma in childhood: our evidence-based approach to management. Childs Nerv Syst 2005;21:660–668.
Gupta DK, Ojha BK, Sarkar C, Mahapatra AK, Mehta VS. Recurrence in craniopharyngiomas: analysis of clinical and histological features. J Clin Neurosci 2006;13:438–442.
Tomita T, Bowman RM. Craniopharyngiomas in children: surgical experience at Children’s Memorial Hospital. Childs Nerv Syst 2005;21:729–746.
Khafaga Y, Jenkin D, Kanaan I, Hassounah M, Al Shabanah M, Gray A. Craniopharyngioma in children. Int J Radiat Oncol Biol Phys 1988;42:601–606.
Vinchon M, Dhellemmes P. Craniopharingiomas in children: recurrence, reoperation and outcome. Childs Nerv Sys 2008;24:211–217.
Darendeliler F, Karagiannis G, Wilton P, Ranke MB, Albertsson-Wikland K, Anthony Price D, et al. Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database). Acta Paediatr 2006;95:1284–1290.
Lena G, Paz Paredes A, Scavarda D, Giusiano B. Craniopharyngioma in children: Marseille experience. Childs Nerv Syst 2005;21:778–784.
Sosa IJ, Krieger MD, McComb JG. Craniopharyngiomas of childhood: the CHLA experience. Childs Nerv Syst 2005;21:785–789.
Rilliet B, Vernet O, Pica A. The Geneva and Lausanne (French-speaking Switzerland) experience: in favor of the transsphenoidal approach when feasible. Childs Nerv Syst 2005;21:725–728.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gucev, Z.S., Danilovski, D., Tasic, V. et al. Childhood craniopharyngioma in Macedonia: incidence and outcome after subtotal resection and cranial irradiation. World J Pediatr 7, 74–78 (2011). https://doi.org/10.1007/s12519-011-0250-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12519-011-0250-3